Procalcitonin test fails to shorten antibiotic use in hospitalized children

A groundbreaking UK study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in hospitals.

Facing a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines

WASHINGTON — Peter Marks wants to keep his job. A top Food and Drug Administration official, Marks arrived Wednesday at the five-star hotel where the Milken

November 14, 2024

Researchers are betting on cockroaches as the cure to elitism in neuroscience

Cockroaches are a hardy pest, and often elicit disgust. But they do have a few things going for them: They are cheap, can be raised

December 10, 2024

Updated: Amgen spotlights new efficacy, safety data of mid-phase tarlatamab trial in hard-to-treat cancer: #ESMO23

MADRID — Amgen’s Phase II trial of its bispecific T cell engager tarlatamab showed a response rate of 40% of patients with small cell lung

October 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.